Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.8587
-0.0363 (-4.06%)
At close: Mar 11, 2026, 4:00 PM EDT
0.8400
-0.0187 (-2.18%)
After-hours: Mar 11, 2026, 7:56 PM EDT
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $185.91 million as of March 11, 2026. Its market cap has increased by 127.84% in one year.
Market Cap
185.91M
Enterprise Value
141.13M
1-Year Change
127.84%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $185.91M, a decrease of -69.20%. That is a compound annual growth rate of -22.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 185.91M | 20.69% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | 603.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 191.66M |
| ProQR Therapeutics | 190.67M |
| Caribou Biosciences | 190.38M |
| Immunic | 189.17M |
| Whitehawk Therapeutics | 188.98M |
| NeOnc Technologies Holdings | 187.04M |
| Sagimet Biosciences | 186.67M |
| Vaxart | 185.42M |